title: Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.
abstract: Immunotherapy is currently being intensively explored as much-needed disease-modifying treatment for neurodegenerative diseases. While Alzheimer's disease (AD) has been the focus of numerous immunotherapeutic studies, less attention has been paid to Parkinson's disease (PD) and other neurodegenerative disorders. The reason for this difference is that the amyloid beta (Aβ) protein in AD is a secreted molecule that circulates in the blood and is readably recognized by antibodies. In contrast, α-synuclein (α-syn), tau, huntingtin and other proteins involved in neurodegenerative diseases have been considered to be exclusively of intracellular nature. However, the recent discovery that toxic oligomeric versions of α-syn and tau accumulate in the membrane and can be excreted to the extracellular environment has provided a rationale for the development of immunotherapeutic approaches for PD, dementia with Lewy bodies, frontotemporal dementia, and other neurodegenerative disorders characterized by the abnormal accumulation of these proteins. Active immunization, passive immunization, and T cell-mediated cellular immunotherapeutic approaches have been developed targeting Aβ, α-syn and tau. Most advanced studies, including results from phase III clinical trials for passive immunization in AD, have been recently reported. Results suggest that immunotherapy might be a promising therapeutic approach for neurodegenerative diseases that progress with the accumulation and propagation of toxic protein aggregates. In this manuscript we provide an overview on immunotherapeutic advances for neurodegenerative disorders, with special emphasis on α-synucleinopathies.
authors: Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
authors: Elvira
authors: E
authors: Valera
authors: Eliezer
authors: E
authors: Masliah
mesh_terms: D000818:Animals; D006801:Humans; D007167:Immunotherapy; D019636:Neurodegenerative Diseases / Q000628:therapy*; D051844:alpha-Synuclein / Q000276:immunology* / Q000378:metabolism
chemical_list: D051844:alpha-Synuclein
references: J Mol Biol. 2008 Mar 14;377(1):136-47
references: 18237741
references: Neuroscience. 2009 Feb 6;158(3):1030-8
references: 18644426
references: Mol Neurodegener. 2012 Aug 24;7:42
references: 22920859
references: Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
references: 21325059
references: J Alzheimers Dis. 2006;9(3 Suppl):425-32
references: 16914881
references: Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908
references: 11215516
references: Expert Opin Ther Targets. 2012 Apr;16(4):421-32
references: 22480256
references: Biochim Biophys Acta. 2000 Jul 26;1502(1):95-109
references: 10899435
references: Neuropathol Appl Neurobiol. 2004 Feb;30(1):1-18
references: 14720172
references: J Neural Transm (Vienna). 2010 Aug;117(8):949-60
references: 20552234
references: Brain Pathol. 2000 Jul;10(3):378-84
references: 10885656
references: J Neurochem. 2011 Aug;118(4):658-67
references: 21644996
references: J Neurol Sci. 1989 Dec;94(1-3):79-100
references: 2559165
references: Brain. 2004 Apr;127(Pt 4):791-800
references: 14749292
references: Nat Rev Drug Discov. 2010 May;9(5):387-98
references: 20431570
references: Nature. 1999 Jul 8;400(6740):173-7
references: 10408445
references: FEBS J. 2007 Apr;274(7):1862-77
references: 17381514
references: Hum Vaccin. 2010 Nov;6(11):948-52
references: 20980801
references: J Neuroimmunol. 2007 Feb;183(1-2):60-8
references: 17196666
references: J Neurosci. 2012 Sep 26;32(39):13454-69
references: 23015436
references: Neurosci Lett. 1989 May 22;100(1-3):6-10
references: 2548130
references: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
references: 19651612
references: CNS Neurol Disord Drug Targets. 2010 Apr;9(2):197-206
references: 20205640
references: Arch Neurol. 2012 Feb;69(2):198-207
references: 21987394
references: Neurodegener Dis. 2004;1(4-5):218-24
references: 16908993
references: CNS Neurol Disord Drug Targets. 2012 Mar;11(2):174-9
references: 22483285
references: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S143-7
references: 20082977
references: Neurology. 2008 Aug 26;71(9):670-6
references: 18725592
references: Neurosci Lett. 1997 Dec 12;239(1):45-8
references: 9547168
references: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4764-9
references: 11296304
references: PLoS One. 2011;6(10):e27230
references: 22073131
references: J Neuroimmunol. 2009 Apr 30;209(1-2):50-6
references: 19232746
references: J Neurosci. 2010 Dec 8;30(49):16559-66
references: 21147995
references: Neoplasia. 2007 Dec;9(12):1099-110
references: 18084617
references: J Neurochem. 2010 Mar;112(6):1353-67
references: 19943854
references: Cell. 2011 Jul 8;146(1):37-52
references: 21700325
references: J Immunol. 2010 Mar 1;184(5):2261-71
references: 20118279
references: Science. 2012 Nov 16;338(6109):949-53
references: 23161999
references: Cell Death Dis. 2012 Jul 19;3:e350
references: 22825468
references: J Immunol. 2009 Jun 15;182(12):7613-24
references: 19494285
references: Neuropathol Appl Neurobiol. 2012 Oct;38(6):559-71
references: 22013984
references: J Biol Chem. 2010 Mar 19;285(12):9262-72
references: 20071342
references: Mol Ther. 2003 May;7(5 Pt 1):569-70
references: 12718897
references: N Engl J Med. 1988 Jan 7;318(1):51
references: 3336384
references: Sci Transl Med. 2011 May 25;3(84):84ra44
references: 21613623
references: Arch Neurol. 1995 Jan;52(1):81-8
references: 7826280
references: PLoS One. 2012;7(10):e46817
references: 23077527
references: J Neurosci. 2007 Aug 22;27(34):9220-32
references: 17715357
references: Lancet Neurol. 2012 Jul;11(7):597-604
references: 22677258
references: Biochemistry. 2012 Mar 27;51(12):2539-50
references: 22401494
references: Hum Mol Genet. 1999;8(10):1901-5
references: 10469843
references: J Neurochem. 2007 Jan;100(2):503-19
references: 17241161
references: J Neurol Neurosurg Psychiatry. 2011 May;82(5):476-86
references: 20971753
references: Mol Genet Metab. 2004 Jan;81(1):70-3
references: 14728994
references: Nat Rev Immunol. 2012 Mar 22;12(4):269-81
references: 22437939
references: Neuron. 2005 Jun 16;46(6):857-68
references: 15953415
references: J Neuroinflammation. 2004 Jul 30;1(1):14
references: 15285801
references: Trends Neurosci. 1998 Oct;21(10):428-33
references: 9786340
references: J Alzheimers Dis. 2008 Dec;15(4):555-69
references: 19096156
references: Neuropathology. 2006 Aug;26(4):338-45
references: 16961071
references: Nanomedicine. 2008 Dec;4(4):350-7
references: 18640077
references: Acta Neuropathol. 1994;88(2):129-36
references: 7985493
references: Brain Res Brain Res Rev. 1995 Mar;20(3):269-87
references: 7550361
references: CNS Neurol Disord Drug Targets. 2009 Apr;8(2):144-59
references: 19355934
references: Am J Pathol. 1999 Oct;155(4):1241-51
references: 10514406
references: Sci Transl Med. 2011 May 25;3(84):84ra43
references: 21613622
references: Nature. 1997 Aug 28;388(6645):839-40
references: 9278044
references: Nature. 2003 Mar 6;422(6927):80-3
references: 12621436
references: Neurosci Lett. 1998 Jun 19;249(2-3):180-2
references: 9682846
references: J Neurosci Res. 2000 Oct 1;62(1):9-14
references: 11002283
references: Genomics. 1998 Apr 1;49(1):143-6
references: 9570960
references: Br J Pharmacol. 2012 Mar;165(5):1246-59
references: 22044248
references: Neurology. 2003 Jul 8;61(1):46-54
references: 12847155
references: Neuron. 1995 Feb;14(2):467-75
references: 7857654
references: Nat Rev Neurol. 2010 Feb;6(2):108-19
references: 20140000
references: Nat Genet. 2006 Oct;38(10):1184-91
references: 16964263
references: Am J Pathol. 2002 Jul;161(1):13-7
references: 12107084
references: J Neurochem. 1999 Nov;73(5):2093-100
references: 10537069
references: Exp Neurol. 2011 Aug;230(2):157-61
references: 20970422
references: Am J Pathol. 1998 Feb;152(2):367-72
references: 9466562
references: Neurodegener Dis. 2005;2(5):255-60
references: 16909006
references: Mt Sinai J Med. 2010 Jan-Feb;77(1):17-31
references: 20101719
references: J Leukoc Biol. 2007 Nov;82(5):1083-94
references: 17675560
references: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S71-3
references: 22166460
references: Neuroreport. 1999 Feb 5;10(2):427-9
references: 10203348
references: CNS Neurol Disord Drug Targets. 2009 Mar;8(1):31-49
references: 19275635
references: Lancet Neurol. 2005 Nov;4(11):771-80
references: 16239184
references: Curr Alzheimer Res. 2011 Sep;8(6):659-65
references: 21605039
references: Neuropathology. 2007 Oct;27(5):484-93
references: 18018485
references: J Alzheimers Dis. 2008 Oct;15(2):157-68
references: 18953105
references: Neuron. 2004 Nov 18;44(4):601-7
references: 15541309
references: Mol Cell Neurosci. 2005 Jun;29(2):259-68
references: 15911350
references: Neurosci Lett. 1997 Jul 11;230(1):49-52
references: 9259461
references: Neurobiol Aging. 2012 Sep;33(9):2225-8
references: 21813214
references: Neurology. 2009 Dec 15;73(24):2061-70
references: 19923550
references: J Intern Med. 2011 Jan;269(1):54-63
references: 21158978
references: J Neurosci. 2011 Jun 22;31(25):9323-31
references: 21697382
references: Ann N Y Acad Sci. 2000;920:16-27
references: 11193145
references: Nat Med. 2008 May;14(5):501-3
references: 18391963
references: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2495-500
references: 17277077
references: Antioxid Redox Signal. 2012 May 1;16(9):869-82
references: 21568830
references: J Biol Chem. 2011 Sep 30;286(39):34457-67
references: 21841002
references: Neurobiol Dis. 2005 Nov;20(2):541-9
references: 15908227
references: J Neurosci. 2005 Nov 23;25(47):10913-21
references: 16306404
references: J Neurosci. 2005 Jun 22;25(25):6016-24
references: 15976091
references: Trends Neurosci. 2010 Jul;33(7):317-25
references: 20493564
references: Brain Pathol. 1999 Oct;9(4):681-93
references: 10517507
references: Hum Gene Ther. 1994 May;5(5):595-601
references: 7914435
references: Curr Alzheimer Res. 2012 May;9(4):397-405
references: 22272619
references: J Neurosci. 2007 Aug 22;27(34):9115-29
references: 17715348
references: Am J Hum Genet. 2011 Sep 9;89(3):398-406
references: 21907011
references: J Biol Chem. 2001 Jul 27;276(30):28212-8
references: 11337491
references: J Neurosci. 2006 Feb 8;26(6):1880-7
references: 16467537
references: Am J Hum Genet. 2011 Jul 15;89(1):168-75
references: 21763483
references: J Neurosci. 2012 Jul 11;32(28):9677-89
references: 22787053
references: Nat Rev Neurol. 2010 Dec;6(12):702-6
references: 21045796
references: Arch Neurol. 1989 Jun;46(6):615-31
references: 2786405
references: Exp Neurol. 2009 Sep;219(1):368-71
references: 19460374
references: Brain. 1994 Apr;117 ( Pt 2):235-43
references: 8186951
references: Nat Rev Mol Cell Biol. 2010 Apr;11(4):301-7
references: 20308987
references: Biochem Biophys Res Commun. 2008 Aug 1;372(3):423-8
references: 18492487
references: J Neuropathol Exp Neurol. 1998 Jul;57(7):690-8
references: 9690673
references: J Neurochem. 2010 Jun;113(5):1188-99
references: 20345765
references: J Biol Chem. 2002 Jan 4;277(1):671-8
references: 11679584
references: J Alzheimers Dis. 2012;28(1):49-69
references: 21955818
references: J Clin Invest. 2011 Feb;121(2):715-25
references: 21245577
references: J Neurosci. 2010 May 5;30(18):6236-46
references: 20445049
references: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11282-6
references: 8248242
references: Acta Neuropathol. 2000 Jan;99(1):14-20
references: 10651022
references: CNS Neurol Disord Drug Targets. 2009 Mar;8(1):65-81
references: 19275637
references: Clin Neuropathol. 2010 Jul-Aug;29(4):209-16
references: 20569670
references: J Neuroinflammation. 2012 May 03;9:84
references: 22554253
references: Neurology. 2000 Mar 14;54(5):1050-8
references: 10720273
references: Dement Geriatr Cogn Disord. 2004;17(4):350-4
references: 15178952
references: Parkinsonism Relat Disord. 1999 Dec;5(4):157-62
references: 18591134
references: Expert Rev Neurother. 2012 May;12(5):535-43
references: 22550982
references: Neurology. 1992 Mar;42(3 Pt 1):631-9
references: 1549228
references: PLoS One. 2011 Apr 29;6(4):e19338
references: 21559417
references: Neuron. 1995 Aug;15(2):361-72
references: 7646890
references: J Mol Biol. 2012 Aug 24;421(4-5):525-36
references: 22197375
references: J Biol Chem. 1986 May 5;261(13):6084-9
references: 3084478
references: Science. 1986 May 2;232(4750):648-50
references: 3083509
references: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S11-3
references: 22166404
references: Am J Hum Genet. 2001 Sep;69(3):629-34
references: 11462174
references: J Alzheimers Dis. 2013;33(2):297-312
references: 23001712
references: J Neuropathol Exp Neurol. 2010 Oct;69(10):1044-56
references: 20838241
references: Mol Ther. 2003 May;7(5 Pt 1):572-9
references: 12718899
references: Alzheimers Dement. 2012 Jul;8(4):261-71
references: 22672770
references: Arch Neurol. 2012 Aug;69(8):1002-10
references: 22473769
references: CNS Neurol Disord Drug Targets. 2009 Apr;8(2):114-27
references: 19355932
references: Acta Neuropathol. 2010 Aug;120(2):131-43
references: 20563819
references: Nat Rev Neurosci. 2010 Mar;11(3):155-9
references: 20029438
references: Curr Pharm Des. 2011;17(5):508-20
references: 21375481
references: J Alzheimers Dis. 2010;21(4):1065-75
references: 21504118
references: Lancet Neurol. 2010 Apr;9(4):363-72
references: 20189881
references: Brain Res Mol Brain Res. 1999 Mar 5;65(2):151-66
references: 10064886
references: Eur J Neurosci. 2006 May;23(10):2635-47
references: 16817866
references: Med Hypotheses. 2005;64(6):1105-8
references: 15823695
references: Mol Ther. 2004 Dec;10(6):1023-31
references: 15564134
references: J Biol Chem. 2012 Jun 1;287(23):19440-51
references: 22461630
references: Neurol India. 2007 Jan-Mar;55(1):11-6
references: 17272893
references: Immunotherapy. 2012 Feb;4(2):213-38
references: 22339463
references: Acta Neuropathol. 2007 Jul;114(1):31-8
references: 17569065
references: J Mol Neurosci. 2011 Nov;45(3):690-5
references: 21739165
references: Proc Natl Acad Sci U S A. 1988 Oct;85(19):7384-8
references: 2459703
references: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S66-70
references: 22166458
references: J Neurochem. 2012 Jan;120 Suppl 1:186-193
references: 21883222
references: Expert Rev Vaccines. 2007 Apr;6(2):153-68
references: 17408366
references: Mol Neurobiol. 2013 Apr;47(2):561-74
references: 22544647
references: Expert Opin Biol Ther. 2011 Mar;11(3):343-57
references: 21261567
references: Prog Neurobiol. 2012 May;97(2):205-19
references: 22115849
references: J Virol. 1995 Mar;69(3):1990-3
references: 7853547
references: Lancet. 2008 Jul 19;372(9634):216-23
references: 18640458
references: Exp Neurol. 2012 Jul;236(1):1-5
references: 22575598
references: Nature. 2002 Jul 18;418(6895):291
references: 12124613
references: Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11563-8
references: 16061794
references: Acta Neuropathol. 2005 Nov;110(5):501-12
references: 16222525
references: Trends Biochem Sci. 1993 Dec;18(12):480-3
references: 8108862
references: J Neuroinflammation. 2010 Dec 07;7:90
references: 21138577
references: Mov Disord. 2009 Apr 30;24(6):833-8
references: 19224617